S.NO
|
COMPANY NAME
|
PRODUCT NAME |
REASON
|
UP TO |
DOWNLOAD |
|---|
| |
M/s Maxchem Pharmaceuticals Pvt.Ltd ,Plot No.22, Sector-3, Sidcul -IIE ,Rudrapur Distt US,Nagar uttarakhand -263153 |
Iron and Folic Acid Suspension [448] |
NOSQ Supply |
03.11.2024 |
Order |
| |
M/s Healer's Lab |
Hydroxychloroquine Sulphate Tablets IP 200 mg |
NON Submission Of Agreement |
27.09.2023 |
NIB03/1777 |
| |
Saar Biotech |
Calcium and Vitamin D3 Suspension [441] |
Nosq product |
15.11.2023 |
1176/16.11.2021 |
| |
Yeluri Formulations Pvt Ltd |
Amoxycillin and Potassium Clavulanate Tabs IP 500 mg + 125mg [70] |
Nosq product |
15.11.2023 |
1177/16.11.2021 |
| |
Medipol Pharmaceuticals India Pvt. Ltd |
Co-Trimoxazole Oral Suspension IP each 5 ML Contains Tirmethoprim 40 Mg and Sulphamethoxazole 200 Mg [107] |
Nosq product |
15.11.2023 |
1179/16.11.2021 |
| |
Pharose Remedies Limited |
Ibuprofen Tab Ip 200 mg(coated) [23] |
Agreement not submitted |
23.12.2024 |
NIB13/3051/2019 |
| |
Biogenetic Drugs |
Iron and Folic Acid suspension Each 5ml contains ferrous fumerate equivalent to elemental iron 100mg,Folic Acid 500 Mcg[448] |
Nosq product |
06.01.2024 |
1523/07.01.2022 |
| |
Ind Swift |
Albendazole tablets IP 400 mg [66A] |
Nosq product |
06.01.2024 |
1521/07.01.2022 |
| |
Meril Diagnostics |
Anti A Blood Grouping Serum Ip (Anti A Monoclonal Serum) [225]
|
Nosq product |
06.01.2024 |
1520/07.01.2022 |
| |
MBS INDIA |
NES-1,NES- 2, NES- 3, NES-4 |
NON Submission of Agreement & non Supply for these items |
26.01.2025 |
NIB17/62/27.01.2022 |
| |
MAHDEV EXPORTS |
PPE KIT |
NON SUBMIssion of Agreement & Processing fess |
26.01.2025 |
NIB12/63/27.01.2022 |
| |
Vijay Latex product Pvt. Ltd. |
S-90 (a), S-90 (b), S-90 ©, S-90 (d) S-5(b) S-6(b) S-7(b) |
For Non Supply for these items |
26.01.2025 |
NIB10/64/27.01.2022 |
| |
Samkit textile millls Pvt Ltd. |
N/95 Mask |
For Non Supply for this items |
26.01.2025 |
NIB19/65/27.01.2022 |
| |
BDR Pharmaceuticals |
Bortezomib Inj. 2mg [730] |
3 continuous PO non supply |
02.02.2024 |
3100/03.02.2022 |
| |
Agron Remedies Pvt Ltd. |
Dexamethasone INj. IP 8mg/2ml [39] |
3 continuous PO non supply |
02.02.2024 |
3096/03.02.2022 |
| |
Medipol Pharmaceuticals |
Glibenclamide and Metformin Hydrochloride (SR) Tablets [Glibenclamide 5 mg, Metformin Hydrochloride 500 mg (Sustained Release)] [453] |
3 continuous PO non supply |
02.02.2024 |
3097/03.02.2022 |
| |
Supermax Laboratories |
Linezolid Tablets IP 600mg [516] |
3 continuous PO non supply |
02.02.2024 |
3099/03.02.2022 |
| |
S M Pharmaceuticals |
Glycerin IP 400mg [217] & Liquid Paraffin IP 400ml [218] |
3 continuous PO non supply |
02.02.2024 |
3098/03.02.2022 |
| |
Scott Edil Pharmacia |
Diclofenac Sodium and Paracetamol Tablets Diclofenac Sodium 50 mg + Paracetamol 325 mg [483] |
3 continuous PO non supply |
02.02.2024 |
3095/03.02.2022 |
| |
Brooks Laboratories |
Acetylcystine Solution USP (Injection) 200mg/ml [500] |
3 continuous PO non supply |
02.02.2024 |
3094/03.02.2022 |
| |
Alliance Biotech |
Amlodipine And Atenolol Tablet (Amlodipine Besilate Equivalent to Amlodipine5mg,Atenolol 50 mg) [461] |
NOSQ, Minor Defects |
16.02.2024 |
1760/17.02.2022 |
| |
Medipol Pharmaceuticals India |
Itraconazole Cap 100 mg[118] |
NOSQ,Grossly Standard |
16.02.2024 |
1758/17.02.2022 |
| |
Orison Pharma Intemational |
Paracetamol Tab IP 500mg [28], Glimepiride Tab IP 1 mg[290], (Montelukast(10mg)+Levocetrizine Tablet (5mg))[660], Clonazepam Tablet 0.5 mg [678], Azithromycin Tab IP 500mg [80A] |
NON Submission Of Agreement |
21.02.2025 |
NIB-27/510/2020/22.02.2021 |
| |
GLS pharmaLtd |
Melphalan Tablets IP 5mg (code no.151) |
3 continuous PO non supply |
27.02.2024 |
2021/3442/28.02.2021 |
| |
Celon laboratories limited |
Vecuronium Bromide for Injection 4mg(Freeze Dired) code no [419] |
3 continuous PO non supply |
27.02.2024
|
2021/3446/28.02.2022 |
| |
Medipol Pharmaceuticals I Pvt ltd |
Prazosin Tablets ( extended release) 2.5 mg and Lamotrigine Tablet IP 50 mg [701] |
Violation of 2(e) tender cond. |
27.02.2024 |
2021/3444/28.02.2022 |
| |
ION Healthcare Pvt.Ltd |
Paracetamol Syrup 125mg/ml ( code no 27)
|
3 continuous PO non supply |
27.02.2024 |
2021/3447/28.02.2022 |
| |
Medipol Pharmaceuticals I Pvt ltd |
Lavamisol Hydrochloride IP 50 mg (code no.785) |
3 continuous PO non supply |
27.02.2024 |
2021/3448/28.02.2022 |
| |
Stallion Laboratories Pvt.Ltd |
Lisinopril Tablet IP 5mg (code no.199) |
3 continuous PO non supply |
27.02.2024 |
2021/3454/28.02.2022 |
| |
S M Pharmaceuticals |
Povidone Iodine Solution IP 5o/o 500ml (Code no 222) |
3 continuous PO non supply |
27.02.2024 |
2021/3453/28.02.2022 |
| |
Rudraksh Pharma & Surgico Pvt Ltd
|
Urine Collecting Bags,Disposable 2000ml( Code no.S40) |
3 continuous PO non supply |
27.02.2024 |
2021/3455/28.02.2022 |
| |
Medipol Pharmaceuticals I Pvt ltd |
Levodopa and Carbidopa Tablets IP Levodopa 100mg+Carbidopa 10mg (code no.160)
|
3 continuous PO non supply |
27.02.2024 |
2021/3456/28.02.2022 |
| |
Ind- Swift Ltd |
Cetirizine Phenylephrine & Paracetamol Tablets (code no. 498) |
3 continuous PO non supply |
27.02.2024 |
2021/3451/28.02.2022 |
| |
Alliance Biotech |
Atorvastatin Tab IP 10 mg[187] |
NOSQ,Grossly Standard |
06.01.2024 |
1986/24.03.2022 |
| |
Kaysons Pharma |
Cough Syrup Each 5 ML Contains Chloropheniramine maleate IP 3 Mg, Ammonium Chloride 130 Mg, Sodium Citrate 65 Mg, Menthol 0.5 Mg, Syrup Q.S.[368]
|
NOSQ,Grossly Standard |
29.05.2024 |
389/30.05.2022 |
| |
Navkar Lifesciences |
Cough Syrup Each 5 Ml Contains Chloropheniramine Maleate IP 3 Mg, Ammonium Chloride 130 Mg, Sodium Citrate 65 Mg, Methol 0.5 Mg, Syrup Q.S.[368]
|
NOSQ,Grossly Standard |
29.05.2024 |
390/30.05.2022 |
| |
Agron Remedies |
Glimepiride Tab IP 2 Mg[289] |
NOSQ,Grossly Standard |
29.05.2024 |
391/30.05.2022 |
| |
Alliance Biotech |
Cetirizine syrup IP 5mg/5 ml [499] |
PO non supply |
07.06.2024 |
811/08.06.2022 |
| |
Shriniwas Polyfabrics and Packwell Pvt Ltd |
Sanitary Napkin Beltless [S99.A] |
3 continuous PO non supply |
07.06.2024 |
812/08.06.2022 |
| |
Sanctus Global Formilations Limited
|
Diclofenac Sod + Paracetamol Tablets IP Diclofenac Sod 50 mg + Paracetamol 325 mg [483] |
3 continuous PO non supply |
07.06.2024 |
822/08.06.2022 |
| |
Biogenetic Drugs Pvt Ltd |
Cetirizine,Phenylephrine & Paracetamol Tablets Cetirizine 5 mg,Phenylephrine 10 mg & Paracetamol 325 mg Tab [498] |
3 continuous PO non supply |
07.06.2024 |
820/08.06.2022 |
| |
Kaysons Pharma |
Anticold Syrup[497] |
3 continuous PO non supply |
07.06.2024 |
821/08.06.2022 |
| |
Orison Pharma International |
Dicyclomine and Paracetamol Tablets Dicyclomine Hydrochloride 20 mg + Paracetamol 325 mg Tablets [439A] |
3 continuous PO non supply |
07.06.2024 |
819/08.06.2022 |
| |
Health Biotech Ltd |
Vincristine Inj IP 1mg(vial)/Vincristin Injection USP 1mg/ml (Amp) [159] |
3 continuous PO non supply |
07.06.2024 |
810/08.06.2022 |
| |
Ind- Swift Ltd |
Anticold syrup [497] |
3 continuous PO non supply |
07.06.2024 |
823/08.06.2022 |
| |
Cosmas Research Lab Ltd |
Aztreonam Injection USP 500 mg [509] |
3 continuous PO non supply |
07.06.2024 |
818/08.06.2022 |
| |
Vivimed Labs Ltd |
Diclofenac Gel: Diclofenac diethylamine 1.16%, Methyl salicylate 10%, Linseed oil 3%, Menthol 5%[493] |
PO non supply |
07.06.2024 |
815/08.06.2022 |
| |
Stallion Laboratories Pvt.Ltd |
Azithromycin Tablets IP 250mg [79A] |
NON Submission Of Agreement |
20.06.2025 |
nib02/1786/2021 |
| |
Scott Edil Advacnce Research Laboratories & education Ltd. |
Cefixime Tab Ip 100mg[84] |
NON Submission Of Agreement |
20.06.2025 |
nib02/1784/2021 |
| |
Orison Pharma Intemational |
Dicyclomine and Paracetamol tablets Dicyclomine Hydrochloride 20 mg +Paracetamol 325 mg Tablets [439A] |
NON Submission Of Agreement |
20.06.2025 |
NIB02/1783/2021 |
| |
Nestor Pharmaceuticals Ltd. |
Amoxycillin and Cloxacillin Cap 250 + 250 mg [69]
|
NON Submission Of Agreement |
20.06.2025 |
NIB02/1785/2021 |
| |
ANG Life Science (I) Ltd |
Metformin Tab IP 500 mg (Film Coated) [295] |
NON Submission Of Agreement |
20.06.2025 |
nib02/1782/2021 |
| |
Agron Remedies Pvt Ltd |
Amoxycillin and Cloxacillin Cap 250 + 250 mg [69], Piperacillin +Tazobactum for Injection IP 4gm +500 mg, Meropenem Inj. IP 1gm & 481, Cefriaxone Inj. IP 1g/vial & 93 |
NON Submission Of Agreement |
20.06.2025 |
nib02/1781/2021 |
| |
Supemax Drugs & Pharmaceuticals Pvt ltd |
Cefoperazone and Sulbactum for Inj. (Cefoperazone Sodium eq.to Cefoperazone1 gm and Sulbactum Sodium 0.5gm) (IM/IV use) |
NON Submission Of Agreement |
20.06.2025 |
nib26/1780/2021 |
| |
Terrace Pharmaceuticals Pvt. Ltd |
Cephalexin Cap IP 500mg [97] |
PO non supply |
16.06.2024 |
977/17.06.2022 |
| |
Scott Edil Advance Research Laboratories & Education Ltd
|
Amoxycillinc Cap IP 250mg [71] |
PO non supply |
16.06.2024 |
976/17.06.2022 |
| |
Agron Remedes Pvt. Ltd |
Amoxycillinc Cap IP 500mg [72] |
PO non supply |
16.06.2024 |
975/17.06.2022 |
| |
Maxmed Lifesciences Private ltd |
Cefotaxime Injection IP 1gm [87] |
NON Submission Of Agreement |
29.06.2025 |
1891/30.06.2022 |
| |
Halewood Laboratories Pvt Ltd |
Ciprofloxacin Tablets IP 250 Mg Film Coated [102] |
NOSQ,Grossly Standard |
31.06.2024 |
712/01.07.2022 |
| |
Vivek Pharmachem (India) Ltd |
Multivitamin Tablets NFI Formula Sugar Coated Vit A 2500 lu Vit B1-2mg Vit-B6-0.5mg Vit-C-50mg Calcium Pantothenate-1mg Vit-D3-200 iu Vit-B2-2 Mg Niacinamide-25mg Folic Acid -0.2Mg[394] |
NOSQ |
06.01.2026 |
713/01.07.2022 |
| |
Shopinterio Limited Liability Partnership |
C-3 (N-95 mask) |
NON Submission Of Agreement |
06.07.2025 |
NIB-07/533/07.07.2022 |
| |
Combitic Global Caplet Pvt.Ltd |
Cefixime Tablets IP 200 mg( Item code 85) |
NON Submission Of Agreement |
20.07.2025 |
NIB22/2260/21.07.2022 |
| |
Cosmas Research Lab Ltd. |
Tab.Amoxycillin 250 mg+ Calvulanic Acid 125 mg IP Each Film Coated tab Contain Amoxycillin Trihydrate IP 250 mg & Potassium Clavulanate IP 125 mg (item code 706) |
NON Submission Of Agreement |
09.08.2025
|
NIB02/2420/2021 |
| |
Babu Ram Om Prakash
|
Providone Iodinc Ointment USP 5% (item code 571) |
NON Submission Of Agreement |
09.08.2025 |
NIB02/2421/2022 |
| |
Orison Pharma International |
266(Domperidone Suspension IP 5mg/5ml), 515 ( levofloxacin tablets IP 250mg), 102 ( Ciprofloxacin Tablets IP 250 mg(Film coated)), 221 (Povidone lodine ointment 5%), 103 (Ciprofloxacin tablets IP 500 mg (FIlm coated)) 123(Metronidazole tablets IP 400 mg(Film Coated))
|
NON Submission Of Agreement |
15.08.2025 |
NIB-22/2021/2434/16.08.2022 |
| |
Aglowmed Limited |
86 (Cefoperazone and Sulbactum for Inj(Cefoperazone sodium eq.to Cefoperazone 1gm and Sulbactum Sodium eq. to Sulbactum 0.5 gm) (IM/IV use)) |
NON Submission Of Agreement |
15.08.2025 |
NIB 26/2021/2434/16.08.2022 |
| |
Medipol Pharmaceuticals Pvt.Ltd |
712 (Tab.Levofloxacin IP 500 mg (Each Film Coated Tablet contains Levofloxacin Hemihydrate IP 500 mg)) |
NON Submission Of Agreement |
15.08.2025 |
NIB-26/201/2464/16.08.2022 |
| |
Medipol Pharmaceuticals Pvt.Ltd |
Tab lamotriginc IP 50 mg (EachSustained Release tablet contains lamotriginc IP 50 mg) Item code 701 |
Non supply |
13.11.2024 |
NIb-14/8516/2022/14.11.2022 |
| |
Pentagaon labs Ltd |
Dextrose Inj. IP 5% [380] |
Non supply |
13.11.2024 |
2633/14.11.2022 |
| |
Health Biotech Ltd |
Vinblastin Inj. IP 10mg/10ml [158] |
Non supply |
13.11.2023 |
2634/14.11.2022 |
| |
Apple Formulations Pvt Ltd |
Drotraverine and Mefenamic Acid Tablets Drotaverine 80mg and Mefenamic Acid 250mg [591] |
Non supply |
13.11.2023 |
2636/14.11.2022 |
| |
Medipol Pharmaceuticals Pvt.Ltd |
Bisacodyl Tab IP 5mg [262] |
Non supply |
13.11.2023 |
2632/14.11.2022 |
| |
Medipol Pharmaceuticals Pvt.Ltd |
Diclofenac Prolonged Release Tablet IP 100mg [437] |
Non supply |
13.11.2024 |
2631/14.11.2022 |
| |
Scott Edil Pharmacia Ltd |
Glimepiride Tab IP 2Mg [289] |
NOSQ,Grossly Standard |
14.11.2023 |
1772/15.11.2022 |
| |
Mercury Laboratories |
Salbutamol Tab IP 2 Mg[373] |
NOSQ,Grossly Standard |
14.11.2023 |
1773/15.11.2022 |
| |
Ind Swift Ltd |
Enalapril Maleate Tab IP 2.5mg[195]
|
NOSQ,Grossly Standard |
14.11.2023 |
1775/15.11.2022 |
| |
Lenus Lifecare Pvt Ltd |
NRD-187 (Ceftriaxone1000mg+Tazobactom 125mg Inj.) |
NON Submission Of Agreement |
21.11.2025 |
NIB10/8588/22.11.2022 |
| |
Vellinton healthcare |
NRD-94 ( Natamycin Opthalmic Suspension 5% Ye Drop IP) |
NON Submission Of Agreement |
21.11.2025 |
NIB 10/8587/22.11.2022 |
| |
Alliance Biotech |
Cetirizne Syrup IP 5mg/5ml [499] |
NOSQ,Grossly Standard |
29.01.2025 |
2432/30.01.2023 |
| |
Healers Lab Unit II |
Glimepiride Tab IP 2Mg [289] |
NOSQ,Grossly Standard |
29.01.2024 |
2438/30.01.2023 |
| |
Healers Lab Unit II |
Alprazolam Tab Ip 0.25 Mg[339] |
NOSQ,Grossly Standard |
29.01.2024 |
2437/30.01.2023 |
| |
Terrace Pharmaceuticals Ltd |
Cephalexin Cap IP 500 Mg[97] |
NOSQ,Grossly Standard |
29.01.2024 |
2436/30.01.2023 |
| |
Sanctus Global FormulationsLtd |
Alprazolam Tab Ip 0.5 Mg[340] |
NOSQ,Grossly Standard |
29.01.2024 |
2435/30.01.2023 |
| |
Combitic Caplet Pvt Ltd |
Enalapril Maleate Tablets IP 10 mg[463] |
NOSQ,Grossly Standard |
29.01.2024 |
2434/30.01.2023 |
| |
Swiss Parenterals Ltd |
Acyclovir Intravenous Infusion IP 250mg[502] |
NOSQ,Grossly Standard |
29.01.2024 |
2433/30.01.2023
|
| |
Saitech Medicare Pvt Ltd |
90 (Ceftazidime Injection IP 250 mg),91 (Ceftazidime Injection IP 500 mg) & 475( Cefpodoxime Dispersible Tablets 50 mg)
|
NON Submission Of Agreement |
07.02.2026 |
NIB 22/483/08.02.2023 |
| |
Medipol Pharmaceuticals I Pvt ltd |
Spironolactone Tab IP 25 mg[258] |
Non supply |
07.02.2024 |
3955/08.02.2023 |
| |
Mascot Health Series |
Nifedipine Tablets IP 10mg ( Sustained Realease) [204] |
Non supply |
07.02.2025 |
3956/08.02.2023 |
| |
Medipol Pharmaceuticals I Pvt ltd |
Gliclazide Tab Ip 40mg[288], Trihexyphenidyl HCL Tab IP 2mg[162],Aspirin Delayed Release Tablet/Aspirin Gastroresistant Tab IP ( Each enteric coated tablet contains acetyl salicylic acid 75 mg) [444] |
Non supply |
07.02.2024 |
3951/08.02.2023 |
| |
Medipol Pharmaceuticals I Pvt. Ltd |
Povidone lodine Scrub Solution/cleasing solution 7 '5 o/ow/v Povidone lodine (suitable for hand wash) [250] |
Non supply |
07.02.2024 |
3952/08.02.2023 |
| |
Medipol pharmaceuticals I Pvt Ltd |
Amiodarone Tab lP 200mg [182] |
Non supply |
07.02.2024 |
3953/08.02.2023 |
| |
Maxmed Life Sciences Pvt. Ltd |
Cephalexin Cap IP 250mg [96] |
Non supply |
07.02.2024 |
3954/08.02.2023 |
| |
Medipol pharmaceuticals India Pvt Ltd |
Tab lamotrigine IP 50 mg ( Each Sustained Release Tablet contains Lamotrigine IP 50 mg ) [701] |
Non supply |
08.02.2025 |
NIB14/500/2022/09.02.2023 |
| |
Omega Pharma |
97 (Cephalexin Cap IP 500 mg) iSfdax 10x10 Cap Blister (Rate should be quoted for 1 Cap) |
NON Submission Of Agreement |
12.02.2026 |
NIb11/516/13.02.2023 |
| |
Sance Laboratories Pvt. Ltd |
86 (Cefoperazone and Sulbactum for Inj (Cefoperazone Sodium eq.to Cefoperazone 1gm and Sulbactum Sodium eq. to Sulbactum 0.5gm)(IM/IV use)) |
NON Submission Of Agreement |
12.02.2026 |
NIB11/515/13.02.2023 |
| |
Maxtar Bio Genics |
661 ( Sodium Valproate Tablet (Gastro Resistant) IP 500mg.) |
NON Submission Of Agreement |
12.02.2026 |
NIB11/514/13.02.2022 |
| |
Unicure India Ltd |
28 (Paracetamol Tab IP 500 mg ) |
NON Submission Of Agreement |
12.02.2026 |
NIB16/513/13.02.2023 |
| |
Healers Lab |
28 (Paracetamol Tab IP 500 mg ) |
NON Submission Of Agreement |
12.02.2026 |
NIB16/513/13.02.2023 |
| |
Prochem Pharmaceuticals Pvt. Ltd |
28 (Paracetamol Tab IP 500 mg ) |
NON Submission Of Agreement |
12.02.2026 |
NIB16/513/13.02.2023 |
| |
Super Formulations Pvt. Ltd |
28 (Paracetamol Tab IP 500 mg ) |
NON Submission Of Agreement |
12.02.2026 |
NIB16/513/13.02.2023 |
| |
Scott-Edil PharmaciaLtd |
28 (Paracetamol Tab IP 500 mg ) |
NON Submission Of Agreement |
12.02.2026 |
NIB16/513/13.02.2023 |
| |
Saitech Medicare Pvt Ltd |
90 (Ceftazidime Injection IP250 mg),91( Ceftazidime Injection IP500 mg) & 475 (Cefpodoxime Dispersible Tablets 50mg) |
NON Submission Of Agreement |
07.02.2026 |
NIB22/483/08.02.2023 |
| |
Maxtar Bio Genics
|
661 (Sodium Valproate tablet (Gastro Resistant) IP 500mg) |
Violation of tender conditions |
12.02.2026 |
NIB11/514/13.02.2023 |
| |
Healers Lab |
79 A( Azithromycin Tablets IP 250mg) |
NON Submission Of Agreement |
09.03.2026 |
NIB02/626/10.03.2023 |
| |
DD Pharmaceuticals Pvt Ltd |
NRD-514(Piracetam 500mg/5ml Suspension/Syrup) |
Violation of tender conditions |
12.04.2026 |
NIB10/719/13.04.2023 |
| |
Kaysons Pharma |
NRD-602(Deflazacort 6mgTab) |
Violation of tender conditions |
12.04.2026 |
NIB10/718/13.04.2023 |
| |
DD Pharmaceuticals Pvt Ltd |
Clobazam Tablet IP/Capsule 5Mg [662] |
NOSQ, Grossly Standard |
18.05.2024 |
428/19.05.2023 |
| |
Adroit Pharmaceuticals PVt Ltc |
Surgical Spirit IP (500 ml) [252] |
NOSQ, Grossly Standard |
18.05.2025 |
429/19.05.2023 |
| |
Healer's LAB UnitII |
Alprazolam Tab IP 0.25 Mg[339] |
NOSQ, Grossly Standard |
18.05.2024 |
430/19.05.2023 |
| |
Sanctus Global Formulations Ltd |
Alprazolam Tab IP 0.5 mg [340] |
NOSQ, Grossly Standard |
18.05.2025 |
431/19.05.2023 |
| |
Unimarck Healthcare Ltd |
Ethamsylate Inj. 250mg/2ml (IM/IV) [173], Hyoscine Butylbromide Inj.IP 20mg/ml [268] |
Non supply |
24.05.2024 |
1034/25.05.2023 |
| |
Cosmas Research Lab Ltd |
Vincristine Inj IP 1mg (vial)/Vincristine Injection USP 1mg/ml (AMp) [159] |
Non supply |
24.05.2024 |
1035/25.05.2023 |
| |
Maxmed Life Sciences Pvt Ltd |
Cefuroxime Axetil Tab IP 250 mg[512] |
Non supply |
24.05.2025 |
1025/25.05.2023 |
| |
Maxmed Life Sciences Pvt Ltd |
Cephalexin Cap IP 250mg[96] |
Non supply |
07.02.2025 |
1025/25.05.2023 |
| |
Medipol Pharmaceuticals I Pvt Ltd |
Prednisolone Tab IP 20 mg [470] |
Non supply |
24.05.2024 |
1026/25.05.2023 |
| |
Medipol Pharmaceuticals I Pvt Ltd |
EscitalopramTAB IP 10mg[351] |
Non supply |
24.05.2025 |
1027/25.05.2023 |
| |
Medipol Pharmaceuticals I Pvt Ltd |
Aspirin Tablet IP (Gastro-Resistant 150mg) [679] |
Non supply |
24.05.2024 |
1029/25.05.2023 |
| |
Medipol Pharmaceuticals I Pvt Ltd |
Hydrochlorthiazole Tab IP 12.5 mg[256] |
Non supply |
24.05.2024 |
1030/25.05.2023 |
| |
Tirupati Medicine Limited |
Itraconazole Cap 100mg [118] |
Non supply |
24.05.2024 |
1032/25.05.2023 |
| |
Medipol Pharmaceuticals I Pvt Ltd |
Providone Iodine Scurb Solution/cleansing solution 7.5% w/v Providone Iodine(suitable for hand wash) [250] |
Non supply |
07.02.2025 |
1028/25.05.2023 |
| |
Unicure (india) Ltd |
Lysol (Cresol with Soap Solution) IP (Cresol 50 o/o +Soap 50 o/o ) [249] |
Non supply |
24.05.2024 |
1033/25.05.2023 |
| |
Medipol Pharmaceuticals I Pvt Ltd |
Tinidazole Tab IP 500mg( Film Coated)[431] |
Non supply |
24.05.2025 |
1031/25.05.2023 |
| |
Agron Remedies Pvt Ltd |
Losartan Potassium & Amlodipine tablets IP (Losartan Potassium 50 mg, Amlodipine Besilate eq. to Amlodipine 5mg)[458] |
Non supply |
24.05.2024 |
1036/25.05.2023 |
| |
Serum Institute of India Pvt Ltd |
rh-Erythropoetin Inj IP 2000 IU [177] |
Non supply |
24.05.2024 |
1037/25.05.2023 |
| |
JPEE Drugs |
Vitamin A Paediatric Oral Solution IP(Vitamin A Concentrate Oil IP)Each Ml Contains Vitamin A 100000 IU[409]
|
NOSQ |
09.07.2024 |
927/10.07.2023 |
| |
Angiplast Private limited |
Catheter, Size 10(Foleys Ballon Catheter Sterile,2 Way For Urinary Drainage, Single Use,)Silicon Coated Natural Latex Material(Details In Rc)[S9.b]
|
NOSQ |
09.01.2024 |
928/10.07.2023 |
| |
Ind Swift Ltd |
Calcium With Vitamin D Tablets USP /Calcium and Colecalciferol Tablets BP/Calcium and Vitamin D3 Tablets IP(Elemental Calcium 500 Mg, Vitamin D3-250 IU) (Non-Chewable)[622] |
NOSQ, Grossly Standard |
09.07.2025 |
929/10.07.2023 |
| |
Alliance Biotech |
Levocetirizine Tablet 5mg[659] |
NOSQ, Grossly Standard |
09.07.2024 |
930/10.07.2023 |
| |
Astam Healthcare Pvt. Ltd |
Amoxycillin And Potassium Clavulanate Tabs IP 500 Mg + 125 Mg[70]
|
NOSQ |
09.07.2024 |
931/10.07.2023 |
| |
Meril Diagnostic Pvt Ltd |
225(Anti A Blood Grouping Serum IP(Anti A Monoclonal Serum)), 226 ( Anti B Blood Grouping Serum IP ( Anti B Mono Clonal Serum)) ,227 ( Anti D (Rh) Blood Grouping Serum IP/Anti D Blood Grouping Serum IP) |
Non violation |
19.07.2025 |
NIB27/1435/20.07.2023
|
| |
Wings Biotech |
Metformin Hcl (Sustained Release) And Glimepiride Tab Metformin Hcl (Sustained Release) 500mg ,Glimepiride 1mg[454] |
NOSQ |
19.09.2024 |
1545/20.09.2023 |
| |
Meril Diagnostics Pvt. Ltd |
Anti B Blood Grouping Serum IP (Anti B Mono Clonal Serum)[226] |
NOSQ |
19.09.2024 |
1543/20.09.2023 |
| |
Cadila Pharmaceuticals |
Biphasic Isophane Insulin Inj IP (30 % Soluble Insulin And 70 % Isophane Insulin) Inj. 40 IU/Ml(R-DNA Origin)[279] |
NOSQ, Grossly Standard |
19.09.2025 |
1544/20.09.2023 |
